Astrid Kok

Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

Cees Mulder, Nicolaas A. Verwey, Wiesje M. van der Flier et al. · Clinical Chemistry · 2009 · 342 citations · Full text

Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

Casper G. Schalkwijk, Dennis C.W. Poland, W. van Dijk et al. · Diabetologia · 1999 · 305 citations · Full text

Inflammation, Vascular Disease, Cardiovascular Disease +10

Contribution of Metabolic Syndrome Components to Cognition in Older Individuals

Miranda G. Dik, Cees Jonker, Hannie C. Comijs et al. · Diabetes Care · 2007 · 253 citations · Full text

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment

Femke H. Bouwman, S.N.M. Schoonenboom, Wiesje M. van der Flier et al. · Neurobiology of Aging · 2006 · 179 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +10

Effects of Processing and Storage Conditions on Amyloid β (1–42) and Tau Concentrations in Cerebrospinal Fluid: Implications for Use in Clinical Practice

Niki S.M. Schoonenboom, Cees Mulder, Hugo Vanderstichele et al. · Clinical Chemistry · 2004 · 159 citations · Full text